Literature DB >> 16253949

Hyaluronan: pharmaceutical characterization and drug delivery.

Yong-Hong Liao1, Stuart A Jones, Ben Forbes, Gary P Martin, Marc B Brown.   

Abstract

Hyaluronic acid (HA), is a polyanionic polysaccharide that consists of N-acetyl-D-glucosamine and beta-glucoronic acid. It is most frequently referred to as hyaluronan because it exists in vivo as a polyanion and not in the protonated acid form. HA is distributed widely in vertebrates and presents as a component of the cell coat of many strains of bacteria. Initially the main functions of HA were believed to be mechanical as it has a protective, structure stabilizing and shock-absorbing role in the body. However, more recently the role of HA in the mediation of physiological functions via interaction with binding proteins and cell surface receptors including morphogenesis, regeneration, wound healing, and tumor invasion, as well as in the dynamic regulation of such interactions on cell signaling and behavior has been documented. The unique viscoelastic nature of hyaluronan along with its biocompatibility and nonimmunogenicity has led to its use in a number of cosmetic, medical, and pharmaceutical applications. More recently, HA has been investigated as a drug delivery agent for ophthalmic, nasal, pulmonary, parenteral, and dermal routes. The purpose of our review is to describe the physical, chemical, and biological properties of native HA together with how it can be produced and assayed along with a detailed analysis of its medical and pharmaceutical applications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16253949     DOI: 10.1080/10717540590952555

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  53 in total

1.  Crude polysaccharide from an anti-UVB cell clone of Bupleurum scorzonerifolium protect HaCaT cells against UVB-induced oxidative stress.

Authors:  Jinran Dai; Haiyin Ma; Jing Fan; Yuzhong Li; Jianguang Wang; Hongmei Ni; Guangmin Xia; Suiyun Chen
Journal:  Cytotechnology       Date:  2011-09-27       Impact factor: 2.058

Review 2.  Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology.

Authors:  Frances E Lennon; Patrick A Singleton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

3.  Alginate/hyaluronic acid hydrogel delivery system characteristics regulate the differentiation of periodontal ligament stem cells toward chondrogenic lineage.

Authors:  Sahar Ansari; Ivana M Diniz; Chider Chen; Tara Aghaloo; Benjamin M Wu; Songtao Shi; Alireza Moshaverinia
Journal:  J Mater Sci Mater Med       Date:  2017-09-15       Impact factor: 3.896

4.  Modulating protein release profiles by incorporating hyaluronic acid into PLGA microparticles Via a spray dryer equipped with a 3-fluid nozzle.

Authors:  Feng Wan; Morten Jonas Maltesen; Sune Klint Andersen; Simon Bjerregaard; Stefania G Baldursdottir; Camilla Foged; Jukka Rantanen; Mingshi Yang
Journal:  Pharm Res       Date:  2014-05-28       Impact factor: 4.200

Review 5.  Future nanomedicine for the diagnosis and treatment of osteoarthritis.

Authors:  Lauren R Eichaker; Hongsik Cho; Craig L Duvall; Thomas A Werfel; Karen A Hasty
Journal:  Nanomedicine (Lond)       Date:  2014-07       Impact factor: 5.307

Review 6.  Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects.

Authors:  Heidi M Mansour; Minji Sohn; Abeer Al-Ghananeem; Patrick P Deluca
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

7.  A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds.

Authors:  Cornelia Tolg; Sara R Hamilton; Ewa Zalinska; Lori McCulloch; Ripal Amin; Natalia Akentieva; Francoise Winnik; Rashmin Savani; Darius J Bagli; Len G Luyt; Mary K Cowman; Jim B McCarthy; Eva A Turley
Journal:  Am J Pathol       Date:  2012-08-11       Impact factor: 4.307

8.  Hyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma.

Authors:  Yu-Jin Jin; Ubonvan Termsarasab; Seung-Hak Ko; Jae-Seong Shim; Saeho Chong; Suk-Jae Chung; Chang-Koo Shim; Hyun-Jong Cho; Dae-Duk Kim
Journal:  Pharm Res       Date:  2012-08-11       Impact factor: 4.200

9.  Intratumoral delivery of Paclitaxel in solid tumor from biodegradable hyaluronan nanoparticle formulations.

Authors:  Abeer M Al-Ghananeem; Ahmad H Malkawi; Yahya M Muammer; Justin M Balko; Esther P Black; Walid Mourad; Edward Romond
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

Review 10.  Hyaluronan regulation of endothelial barrier function in cancer.

Authors:  Patrick A Singleton
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.